G. Meola

10.0k total citations
234 papers, 6.7k citations indexed

About

G. Meola is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, G. Meola has authored 234 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 164 papers in Molecular Biology, 158 papers in Cellular and Molecular Neuroscience and 60 papers in Neurology. Recurrent topics in G. Meola's work include Genetic Neurodegenerative Diseases (145 papers), Mitochondrial Function and Pathology (75 papers) and Muscle Physiology and Disorders (60 papers). G. Meola is often cited by papers focused on Genetic Neurodegenerative Diseases (145 papers), Mitochondrial Function and Pathology (75 papers) and Muscle Physiology and Disorders (60 papers). G. Meola collaborates with scholars based in Italy, United States and United Kingdom. G. Meola's co-authors include Rosanna Cardani, Valeria Sansone, G. Scarlato, Nereo Bresolin, Richard T. Moxley, Louis J. Ptáček, E. Mancinelli, Enrico Bugiardini, Fabio Martelli and Anne Chomyn and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

G. Meola

227 papers receiving 6.5k citations

Peers

Countries citing papers authored by G. Meola

Since Specialization

Citations

This map shows the geographic impact of G. Meola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Meola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Meola more than expected).

Fields of papers citing papers by G. Meola

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Meola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Meola. The network helps show where G. Meola may publish in the future.

Co-authorship network of co-authors of G. Meola

This figure shows the co-authorship network connecting the top 25 collaborators of G. Meola. A scholar is included among the top collaborators of G. Meola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Meola. G. Meola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluation of Sleep-Disordered Breathing and Respiratory Dysfunction in Children with Myotonic Dystrophy Type 1—A Retrospective Cross-Sectional Study 2025 ·Biomedicines ·(unknown), Jovan Pešović, Dušanka Savić‐Pavićević, Stojan Perić, G. Meola, Alessandro Amaddeo, Gordana Kovačević, (unknown), Aleksandar Sovtić	0
2	Transcranial brain parenchyma sonographic findings in patients with myotonic dystrophy type 1 and 2 2024 ·Heliyon ·Milija Mijajlović, Ivo Božović, Aleksandra Pavlović, Vidosava Rakočević-Stojanović, (unknown), (unknown), Ivana Basta, G. Meola, (unknown)	3
3	Myotonic dystrophies: an update on clinical features, molecular mechanisms, management, and gene therapy 2024 ·Neurological Sciences ·M. Rimoldi, Sabrina Lucchiari, Serena Pagliarani, G. Meola, Giacomo P. Comi, Elena Abati	3
4	Myotonic dystrophy type 1 in the COVID-19 era 2023 ·Neurological Sciences ·Jelena Ilić-Živojinović, (unknown), Ivo Božović, G. Meola, Marina Perić, (unknown), Ivana Basta, Vidosava Rakočević-Stojanović, Stojan Perić	0
5	Cognitive assessment in patients with myotonic dystrophy type 2 2022 ·Neuromuscular Disorders ·Stojan Perić, (unknown), (unknown), (unknown), (unknown), Jovan Pešović, (unknown), (unknown), Dušanka Savić‐Pavićević, G. Meola, Vidosava Rakočević-Stojanović	4
6	Clinical score for early diagnosis of myotonic dystrophy type 2 2022 ·Neurological Sciences ·(unknown), Stojan Perić, Jovan Pešović, (unknown), Ivo Božović, (unknown), Dušanka Savić‐Pavićević, G. Meola, Vidosava Rakočević-Stojanović	1
7	Understanding the Impact of Non-Dystrophic Myotonia on Patients and Caregivers: Results from a Burden of Disease Healthcare Survey 2021 ·SHILAP Revista de lepidopterología ·Jordi Díaz‐Manera, Channa Hewamadduma, G. Meola, Federica Montagnese, Sabrina Sacconi, (unknown), (unknown), (unknown), (unknown)	4
8	Lesion distribution and substrate of white matter damage in myotonic dystrophy type 1: Comparison with multiple sclerosis 2021 ·NeuroImage Clinical ·(unknown), Laura Serra, Davide Esposito, (unknown), Giovanni Giulietti, Gabriella Silvestri, Antonio Petrucci, G. Meola, Leonardo Lopiano, Mara Cercignani, Marco Bozzali	8
9	Molecular and Clinical Implications of Variant Repeats in Myotonic Dystrophy Type 1 2021 ·International Journal of Molecular Sciences ·Stojan Perić, Jovan Pešović, Dušanka Savić‐Pavićević, Vidosava Rakočević Stojanović, G. Meola	18
10	Guidelines on clinical presentation and management of nondystrophic myotonias 2020 ·Muscle & Nerve ·Bas C. Stunnenberg, Samantha LoRusso, W. David Arnold, Richard J. Barohn, Stephen C. Cannon, Bertrand Fontaine, Robert C. Griggs, Michael G. Hanna, Emma Matthews, G. Meola, Valeria Sansone, Jaya Trivedi, Baziel G.M. van Engelen, Savine Vicart, Jeffrey Statland	46
11	SCN4A as modifier gene in patients with myotonic dystrophy type 2 2018 ·Scientific Reports ·Anna Binda, Laura Valentina Renna, Francesca Bosè, (unknown), Annalisa Botta, Rea Valaperta, Barbara Fossati, Ilaria Rivolta, G. Meola, Rosanna Cardani	14
12	rbFOX1/MBNL1 competition for CCUG RNA repeats binding contributes to myotonic dystrophy type 1/type 2 differences 2018 ·Nature Communications ·Chantal Sellier, Estefanía Cerro-Herreros, Markus Blatter, Fernande Freyermuth, Angéline Gaucherot, Frank Ruffenach, Partha S. Sarkar, Jack Puymirat, Bjarne Udd, John Day, G. Meola, Guillaume Bassez, Harutoshi Fujimura, Masanori Takahashi, Benedikt Schoser, Denis Furling, Rubén Artero, Frédéric H.‐T. Allain, Beatriz Llamusí, Nicolas Charlet‐Berguerand	57
13	Myotonic dystrophy type 2 and modifier genes: an update on clinical and pathomolecular aspects 2017 ·Neurological Sciences ·G. Meola, Rosanna Cardani	29
14	Plasma microRNAs as biomarkers for myotonic dystrophy type 1 2014 ·Neuromuscular Disorders ·Alessandra Perfetti, Simona Greco, Enrico Bugiardini, Rosanna Cardani, (unknown), Carlo Gaetano, G. Meola, Fabio Martelli	57
15	RNA Foci, CUGBP1, and ZNF9 Are the Primary Targets of the Mutant CUG and CCUG Repeats Expanded in Myotonic Dystrophies Type 1 and Type 2 2011 ·American Journal Of Pathology ·Karlie Jones, Bingwen Jin, Polina Iakova, Claudia Huichalaf, Partha S. Sarkar, Christiane Schneider‐Gold, Benedikt Schoser, G. Meola, Ann‐Bin Shyu, Nikolai A. Timchenko, Lubov Timchenko	31
16	Serbian Validation of the Individualized Neuromuscular Quality of Life Questionnaire (INQoL) in Adults With Myotonic Dystrophy Type 1 2011 ·Journal of Neurology Research ·Stojan Perić, Valeria Sansone, Dragana Lavrnić, G. Meola, Ivana Basta, (unknown), Vidosava Rakočević-Stojanović	8
17	Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis 2008 ·Neurology ·Emma Matthews, Robyn Labrum, Mary G. Sweeney, Richa Sud, A. Haworth, Patrick F. Chinnery, G. Meola, Stéphanie Schorge, Dimitri M. Kullmann, Mary B. Davis, Michael G. Hanna	144
18	Colocalization of ribonuclear inclusions with muscle blind like-proteins in a family with myotonic dystrophy type 2 associated with a short CCTG expansion 2008 ·Journal of the Neurological Sciences ·Sabrina Lucchiari, Serena Pagliarani, Stefania Corti, E. Mancinelli, Maura Servida, (unknown), Valeria Sansone, Maurizio Moggio, Nereo Bresolin, Giacomo P. Comi, G. Meola	9
19	Cytoplasmic restoration and persistence of glucose-6-phosphate dehydrogenase activity in stable hybrid myotubes. 1993 ·PubMed ·Valerio Sansone, G Rotondo, Giovanni Bottiroli, Jacques P. Tremblay, G. Meola	1
20	Type 2 atrophy in a pentazocine addicted patient 1979 ·Neurological Sciences ·C. Mariani, (unknown), (unknown), S. Bassi, G. Meola	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact